HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
HOME
HK STOCK
Announcement
On January 22, LIVZON PHARMA (01513) spent 117.54 million yuan to repurchase 326,000 A shares.
22/01/2025
GMT Eight
LIVZON PHARMA (01513) announced that it will spend 117.54 million RMB to repurchase 326,000 A shares on January 22, 2025.
HG SEMI(06908): The subscription rate for the rights issue is approximately 74.74%
CHINARES PHARMA(03320): China Resources Boya Bio-pharmaceutical Group(300294.SZ) expects the net profit attributable to the parent company to increase by about 380-480 million yuan in 2024 compared to the previous year.
RECOMMEND
HK Stock Market Move | Chip stocks rally across the board Semiconductor companies intensively disclose performance pre-earnings beats. Institutions claim that localization remains the core growth logic.
24/01/2025
HK Stock Market Move |
24/01/2025
HK Stock Market Move | TRIP.COM-S (09961) rose more than 4% with high certainty of increased consumption for the Spring Festival travel. Inbound tourism business may serve as a strong catalyst for the company.
24/01/2025
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com